‘Both Covishield and Covaxin cleared as safe and effective against COVID’

Prime Minister Narendra Modi on Thursday took the second dose of the Covid-19 vaccine at the All India Institute of Medical Sciences (AIIMS) in New Delhi. The..

Earlier, on March 1, PM Modi had taken the first dose of Bharat Biotech's Covaxin at AIIMS Delhi

Mexico’s health regulator COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) has granted approval for emergency use to India’s..

‘Availability is low across the country’

10-member Subject Expert Committee had cleared Covaxin for restricted emergency use in January

In the meeting, Bharat Biotech presented amendments in the approved Phase 3 clinical trial protocol.

Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial..

If approved, Sputnik will join Covaxin and Covishield in the COVID-19 immunisation programme

Bharat Biotech said it is working towards resolving the issues cited during the inspection and the order of 20 million doses from the Brazilian government is..

The Centre on Tuesday (March 30, 2021) announced that the two COVID-19 vaccines Covishield and Covaxin are effective against the UK and the Brazillian variants..

Both Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was..

They had taken the 1st dose of indigenously developed Covaxin by Bharat Biotech on March 2. Vardhan has been appealing to all those aged 60 and above and aged 45..

The detection of double mutant Covid strain in some Bengal patients has left experts and those waiting to get vaccinated worried about the efficacy of..

Scores of recipients have refused to take Covaxin — India’s home-grown vaccine which is backed by the government — across Kolkata’s private hospitals,..

More vaccines likely from July, August, says V.K. Paul

More vaccines likely from July, August, says V.K. Paul

The health ministry on Monday revised the interval between two doses of the Covishield vaccine to 4-8 weeks, from the existing 4-6 weeks, after evidence showed..

Notably, the new guidelines are only applicable to the Covishield vaccine and not the Covaxin coronavirus vaccine.

Notably, the new guidelines are only applicable to the Covishield vaccine and not the Covaxin coronavirus vaccine.

The Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8..

India’s first indigenous Covid-19 vaccine Covaxin, developed by Bharat Biotech and Indian Council of Medical Research-National Institute of Virology, Pune,..

The challenge will be in continuing the trial with 25,800 participants till 130 cases are reported when there is a surge in many States

Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's Covaxin, becoming the third country to approve India's..

Both of them took Covaxin, India’s indigenous COVID-19 vaccine developed by Hyderabad-based Bharat Biotech

As per a recently published report in a Lancet study, Covaxin is completely safe for use and offers a higher efficacy rate than what was previously seen.

A select list of stories to read before you start your day.